KR860004082A - 황산 크실란의 제조방법 - Google Patents

황산 크실란의 제조방법 Download PDF

Info

Publication number
KR860004082A
KR860004082A KR1019850008307A KR850008307A KR860004082A KR 860004082 A KR860004082 A KR 860004082A KR 1019850008307 A KR1019850008307 A KR 1019850008307A KR 850008307 A KR850008307 A KR 850008307A KR 860004082 A KR860004082 A KR 860004082A
Authority
KR
South Korea
Prior art keywords
active ingredient
medicament according
sulfate
xylan sulfate
preparing
Prior art date
Application number
KR1019850008307A
Other languages
English (en)
Inventor
벨이올 알렝 (외 4)
Original Assignee
미쉘 드 아스 (외 1)
사노피 소시에떼아노님
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 미쉘 드 아스 (외 1), 사노피 소시에떼아노님 filed Critical 미쉘 드 아스 (외 1)
Publication of KR860004082A publication Critical patent/KR860004082A/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0057—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Xylans, i.e. xylosaccharide, e.g. arabinoxylan, arabinofuronan, pentosans; (beta-1,3)(beta-1,4)-D-Xylans, e.g. rhodymenans; Hemicellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

내용 없음

Description

황산 크실란의 제조방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (6)

  1. 평균 황화도가 1.5-2이고 우론산 %가 0-10이고 펜토스의 %가 30-40인 황산크실란에 있어서, 평균분자량이 2000-5000달톤인 것을 특징으로 하는 황산크실란
  2. SP54폴리황산크실란을 분류시키는 것을 특징으로 하는 황산크실란의 제조방법.
  3. 제2항에 있어서, 분류가 한외여과로 이루어진는 것을 특징으로 하는 방법
  4. 제1항에 정의한 화합물을 활성성분으로 포함하여 항트롬빈 및 지방분해 활성을 갖는 의약.
  5. 제4항에 있어서, 치료적으로 허용되는 기구 또는 부형제와 결합하여 경구, 비경구, 직장 또는 국부 투여가능한 형태의 의약.
  6. 제5항에 있어서, 각 단위투여당 활성성분을 0.030-1.0g 포함하는 의약
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019850008307A 1984-11-07 1985-11-07 황산 크실란의 제조방법 KR860004082A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8417460A FR2572731B1 (fr) 1984-11-07 1984-11-07 Nouveaux sulfates de xylanes de bas poids moleculaires, leur procede de preparation et leur activite antithrombotique et hypolipemiante par voie orale
FR84-17460 1984-11-07

Publications (1)

Publication Number Publication Date
KR860004082A true KR860004082A (ko) 1986-06-16

Family

ID=9309636

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019850008307A KR860004082A (ko) 1984-11-07 1985-11-07 황산 크실란의 제조방법

Country Status (14)

Country Link
US (1) US4713373A (ko)
EP (1) EP0184480A1 (ko)
JP (1) JPS61197601A (ko)
KR (1) KR860004082A (ko)
AU (1) AU4984585A (ko)
CA (1) CA1247091A (ko)
DK (1) DK510585A (ko)
ES (1) ES8605286A1 (ko)
FR (1) FR2572731B1 (ko)
GR (1) GR852681B (ko)
IL (1) IL76886A0 (ko)
NZ (1) NZ214094A (ko)
PT (1) PT81440B (ko)
ZA (1) ZA858532B (ko)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4966890A (en) * 1986-04-04 1990-10-30 Angiogenics, Ltd. Method and composition for arresting angiogenesis and capillary, cell or membrane leakage
US4820693A (en) * 1986-05-22 1989-04-11 Angiogenics, Ltd. Method and composition for arresting angiogenesis and capillary, cell or membrane leakage
US5668116A (en) * 1987-03-19 1997-09-16 Anthropharm Pty. Limited Anti-inflammatory compounds and compositions
US5145841A (en) * 1987-03-19 1992-09-08 Arthropharm Pty. Limited Anti-inflammatory compounds and compositions
US5484777A (en) * 1989-04-20 1996-01-16 Lange, Iii; Louis G. Pancreatic cholesterol esterase inhibitor
US5017565A (en) * 1989-04-20 1991-05-21 Lange Iii Louis G Use of sulfated polysaccharides to inhibit pancreatic cholesterol esterase
US5063210A (en) * 1989-04-20 1991-11-05 Lange Iii Louis G Use of sulfated polysaccharides to decrease cholesterol and fatty acid absorption
US5141928B1 (en) * 1989-12-20 1995-11-14 Brujo Inc Ophthalmic medication
US5382570A (en) * 1990-04-23 1995-01-17 Akzo, N.V. Sulfated glycosaminoglycanoid derivatives of the dermatan sulfate and chondroitin sulfate type
US5378829A (en) * 1990-04-23 1995-01-03 Akzo N.V. Sulfated glycosaminoglycanoid derivatives of the heparin and heparan sulfate type
US5668274A (en) * 1991-04-23 1997-09-16 Akzo Nobel N.V. Sulfated glycosaminoglycanoid derivatives of the dermatan sulfate and chondroitin sulfate type
US5639469A (en) * 1994-06-15 1997-06-17 Minnesota Mining And Manufacturing Company Transmucosal delivery system
US6255295B1 (en) 1996-12-23 2001-07-03 Nutramax Laboratories, Inc. Aminosugar, glycosaminoglycan or glycosaminoglycan-like compounds, and s-adenosylmethionine composition for the protection, treatment, repair, and reduction of inflammation of connective tissue
US6451771B1 (en) 1999-02-12 2002-09-17 Nutramax Laboratories, Inc. Use of anabolic agents anti-catabolic agents and antioxidant agents for protection treatment and repair of connective tissues in humans and animals
US20070141181A1 (en) 1998-02-13 2007-06-21 Nutramax Laboratories, Inc. Use of anabolic agents, anti-catabolic agents, antioxidant agents, and analgesics for protection, treatment and repair of connective tissues in humans and animals
US6797289B2 (en) * 1998-02-13 2004-09-28 Nutramax Laboratories, Inc. Use of anabolic agents, anti-catabolic agents, antioxidant agents, and analgesics for protection, treatment and repair of connective tissues in humans and animals
FR2797768B1 (fr) * 1999-09-01 2003-06-13 Ifremer Utilisation d'un polysaccharide sulfate de bas poids moleculaire pour l'obtention d'un medicament actif contre la thrombose vasculaire
WO2008107906A1 (en) * 2007-03-06 2008-09-12 Alembic Limited Process for the preparation of pentosan polysulfate or salts thereof
DK2164501T3 (en) * 2007-05-31 2016-05-30 Paradigm Biopharmaceuticals Ltd Sulfated xylans for the treatment or prophylaxis of respiratory diseases
FI121811B (fi) * 2007-06-01 2011-04-29 Upm Kymmene Corp Uudet dispersiot ja menetelmä niiden valmistamiseksi
WO2009047699A1 (en) * 2007-10-10 2009-04-16 Alembic Limited An improved process for the preparation of an amorphous form of pentosan polysulfate or salts thereof
WO2009087581A1 (en) * 2008-01-04 2009-07-16 Alembic Limited An improved process for the preparation of pentosan polysulfate or salts thereof
AU2008100725B4 (en) 2008-07-04 2008-10-02 Parnell Technologies Pty Ltd A sulfated polysaccharide compound for clinical use
AU2013202633B2 (en) * 2008-07-04 2015-10-22 Parnell Technologies Pty Ltd A sulfated polysaccharide compound and the preparation and use thereof
WO2012101544A1 (en) 2011-01-29 2012-08-02 Alembic Pharmaceuticals Limited An improved process for the preparation of pentosan polysulfate or salts thereof
WO2012114349A1 (en) 2011-02-23 2012-08-30 Cadila Healthcare Limited An improved process for the preparation of pentosan polysulfate sodium
CA2861077A1 (en) * 2012-01-30 2013-08-08 Baxter International Inc. Non-anticoagulant sulfated or sulfonated polysaccharides
ITMI20130112A1 (it) * 2013-01-24 2014-07-25 Chemi Spa Metodo di qualificazione di preparazioni di pentosan polifosfato, sue materie prime e processi di produzione
JP6225321B1 (ja) 2016-08-31 2017-11-08 王子ホールディングス株式会社 ポリ硫酸ペントサンの製造方法
KR102559743B1 (ko) 2016-08-31 2023-07-25 오지 홀딩스 가부시키가이샤 산성 자일로올리고당의 제조 방법 및 산성 자일로올리고당
JP6281659B1 (ja) 2017-02-28 2018-02-21 王子ホールディングス株式会社 ポリ硫酸ペントサン、医薬組成物及び抗凝固剤
BR112019025030A2 (pt) 2017-05-31 2020-06-16 Oji Holdings Corporation Preparação umidificante tópica.
MX2020002726A (es) * 2017-09-12 2020-07-20 Oji Holdings Corp Polisulfato de pentosan y metodo para producir polisulfato de pentosan.
EP3730521B1 (en) 2017-12-20 2023-05-17 Oji Holdings Corporation Pentosan polysulfate and medicine containing pentosan polysulfate
EP3666798A1 (de) * 2018-12-11 2020-06-17 Lenzing Aktiengesellschaft Xylan aufweisende zusammensetzung und verfahren zur herstellung einer xylan aufweisenden zusammensetzung
CN115991798B (zh) * 2023-02-16 2024-02-06 南京工业大学 一种生物基半纤维素薄膜材料及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3118588C2 (de) * 1981-05-11 1983-07-07 Luitpold-Werk, Chemisch-Pharmazeutische Fabrik, 8000 München Verfahren zur Herstellung eines injizierbaren hochreinen Chondroitinpolysulfates, hiernach erhältliches Produkt und pharmazeutische Zusammensetzung
FR2543145B1 (fr) * 1983-03-24 1986-10-17 Sanofi Sa Nouveaux sulfates de xylanes, leur procede de preparation et leur activite anti-thrombotique et hypolipemiante

Also Published As

Publication number Publication date
PT81440A (fr) 1985-12-01
US4713373A (en) 1987-12-15
FR2572731B1 (fr) 1987-03-06
AU4984585A (en) 1986-05-15
ZA858532B (en) 1986-07-30
IL76886A0 (en) 1986-02-28
DK510585D0 (da) 1985-11-05
ES8605286A1 (es) 1986-03-16
NZ214094A (en) 1988-01-08
FR2572731A1 (fr) 1986-05-09
PT81440B (fr) 1987-04-09
DK510585A (da) 1986-05-08
JPS61197601A (ja) 1986-09-01
CA1247091A (fr) 1988-12-20
GR852681B (ko) 1986-03-10
ES548577A0 (es) 1986-03-16
EP0184480A1 (fr) 1986-06-11

Similar Documents

Publication Publication Date Title
KR860004082A (ko) 황산 크실란의 제조방법
ES8201596A1 (es) Procedimiento de obtencion de mucopolisacaridos
EP0244178A3 (en) Intraocular dosage compositions and method of use
CA2179682A1 (en) Pharmaceutical, orally applicable composition
FR2596393B1 (fr) Derives de l'acide hydroxy-3 dihydroxyoxophosphorio-4 butanoique, leur procede de preparation, leur application comme medicament et les compositions les renfermant
IT8748097A0 (it) Composizioni farmaceutiche con azione sistemica, applicabili in modo topico
IE831611L (en) Topical anti-inflammatory compositions
IT1212778B (it) Composizioni farmaceutiche adattivita' antiinfiammatoria e/o analgesica, non ulcerogene.
EP0045617A3 (en) Pharmaceutical composition
KR860000865A (ko) 약제 제형의 제조방법
EP0125759A3 (en) Topical composition of antibiotics for application to the mucosa
KR880013534A (ko) 콘 돔
KR910000158A (ko) 의약용 화합물 및 그것의 사용방법
FR2615512B1 (fr) Composes de benzamides substitues pharmacologiquement actifs, compositions pharmaceutiques contenant ces composes, et leur procede de preparation
OA07525A (fr) Dérivés d'acides-animés, leur préparation et utilisation ainsi que les compositions contenant ces dérivés.
ES2039377T3 (es) Un supositorio.
AU2004083A (en) Compressed hydroxybutryic acid polymer retarded release vehicle
DE3578597D1 (de) 4-phenylphthalazin-derivate, deren herstellung und diese enthaltende pharmazeutische zusammenstellungen.
KR890009868A (ko) 1-메틸-β-옥소-α-(페닐카바모일)-2- 피롤프로피오니트릴의 트로메트아민염
KR880009656A (ko) 국소 치근막 질환의 치료 또는 예방법
KR960003718A (ko) 말초신경병 및 중추신경변성병의 치료에 유용한 의약의 제조를 위한 이펜프로딜 및 그 부분입체이성질체의 이용
IT1185745B (it) Derivati ammino 1-fenil-2-ammio-1,3-propandiol-n-alchilici e procedimento epr la loro preparazione
KR910018030A (ko) 뇌의 노화 및 중추신장계 기능 결손 상태의 예방 및 치료를 위한 더마탄 설페이트의 용도
KR880000094A (ko) 위염치료제
IE780530L (en) Anti-histamine salts and compositions

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E902 Notification of reason for refusal
E601 Decision to refuse application